ArticleDrugs - real world outcomes2024

Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective Study.

Yuka Obayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.